Identification of Novel Proteasome Inhibitors from an Enaminone Library

被引:4
作者
Elliott, Megan L. [1 ,2 ]
Thomas, Kevin [1 ]
Kennedy, Steven [1 ,3 ]
Koduri, Naga D. [1 ]
Hussaini, R. Syed [1 ]
Sheaff, Robert J. [1 ]
机构
[1] Univ Tulsa, Dept Chem & Biochem, Tulsa, OK 74104 USA
[2] Oklahoma State Univ, Coll Osteopath Med, Tulsa, OK 74107 USA
[3] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada
基金
美国国家科学基金会;
关键词
biological screening; drug design; peptidomimetic; protease and ligands; therapeutic target; PROTEIN-DEGRADATION; BUILDING-BLOCKS; PYRAZOLES; MECHANISMS;
D O I
10.1111/cbdd.12496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A library of structurally distinct enaminones was synthesized using sonication or Ru(II) catalysis to couple primary, secondary, and tertiary thioamides with -halocarbonyls or -diazocarbonyls. Screening the library for proteasome inhibition using a luciferase-based assay identified seven structurally diverse compounds. Two of these molecules targeted luciferase, while the remaining five exhibited varying potency and specificity for the trypsin-like, chymotrypsin-like, or caspase-like protease activities of the proteasome. Physiological relevance was confirmed by showing these molecules inhibited proteasomal degradation of the full-length protein substrate p21cip1 expressed in tissue culture cells. A cell viability analysis revealed that the proteasome inhibitors differentially affected cell survival. Results indicate a subset of enaminones and precursor molecules identified in this study are good candidates for further development into novel proteasome inhibitors with potential therapeutic value.
引用
收藏
页码:322 / 332
页数:11
相关论文
共 50 条
  • [1] The development of proteasome inhibitors as anticancer drugs
    Adams, J
    [J]. CANCER CELL, 2004, 5 (05) : 417 - 421
  • [2] The proteasome:: Paradigm of a self-compartmentalizing protease
    Baumeister, W
    Walz, J
    Zühl, F
    Seemuller, E
    [J]. CELL, 1998, 92 (03) : 367 - 380
  • [3] Luciferase inhibition by a novel naphthoquinone
    Bedford, Rebecca
    LePage, Daniel
    Hoffmann, Rachel
    Kennedy, Steven
    Gutschenritter, Tyler
    Bull, Lauren
    Sujijantarat, Nanthiya
    DiCesare, John C.
    Sheaff, Robert J.
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2012, 107 : 55 - 64
  • [4] Syn diastereoselectivity in the synthesis of homoallylamine using crotylsilane in the three-component reaction
    Billet, M
    Klotz, P
    Mann, A
    [J]. TETRAHEDRON LETTERS, 2001, 42 (04) : 631 - 634
  • [5] Induction of Cell Death by a Novel Naphthoquinone Containing a Modified Anthracycline Ring System
    Carvajal, Denisse
    Kennedy, Steven
    Boustani, Andre
    Lazar, Monica
    Suong Nguyen
    DiCesare, John C.
    Sheaff, Robert J.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (05) : 764 - 777
  • [6] Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
    Chen, D.
    Frezza, M.
    Schmitt, S.
    Kanwar, J.
    Dou, Q. P.
    [J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (03) : 239 - 253
  • [7] The proteasome, a novel protease regulated by multiple mechanisms
    DeMartino, GN
    Slaughter, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22123 - 22126
  • [8] SYNTHESIS AND STRUCTURAL DETERMINATION OF 5H-BENZOCYCLOHEPTEN-5,8-IMINES
    DICESARE, JC
    BURGESS, JP
    MASCARELLA, SW
    CARROLL, FI
    ROTHMAN, RB
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 1994, 31 (01) : 187 - 192
  • [9] SYNTHESIS, REACTIONS, AND PRELIMINARY EVALUATIONS OF ENAMINONE ESTERS
    EDAFIOGHO, IO
    MOORE, JA
    FARRAR, VA
    NICHOLSON, JM
    SCOTT, KR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (01) : 79 - 84
  • [10] SYNTHESIS AND ANTICONVULSANT ACTIVITY OF ENAMINONES
    EDAFIOGHO, IO
    HINKO, CN
    CHANG, HJ
    MOORE, JA
    MULZAC, D
    NICHOLSON, JM
    SCOTT, KR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) : 2798 - 2805